Page 39 - GTM-1-1

Global Translational Medicine Inflammatory gene-environment interactions in COPD

12. Barnes PJ, 2018, Targeting cytokines to treat asthma and A likely key to EMT-associated COPD pathogenesis.
chronic obstructive pulmonary disease. Nat Rev Immunol, Respirology, 22(1): 133–140.
18(7): 454–466.
https://doi.org/10.1111/resp.12882
https://doi.org/10.1038/s41577-018-0006-6
24. Tam A, Leclair P, Li LV, et al., 2021, FAM13A as potential
13. Wei H, Li B, Sun A, et al., 2019, Interleukin-10 family therapeutic target in modulating TGF-β-induced airway
cytokines immunobiology and structure. In: Jin T, Yin Q, tissue remodeling in COPD. Am J Physiol Lung Cell Mol
editors. Structural Immunology. Advances in Experimental Physiol, 321(2): L377–L391.
Medicine and Biology. Vol. 1172. Singapore: Springer. p79–96.
https://doi.org/10.1152/ajplung.00477.2020
https://doi.org/10.1007 / 978-981-13-9367-9_4
25. Müller-Eberhard HJ, 1988, Molecular organization and function
14. Ouyang W, Rutz S, Crellin NK, et al., 2011, Regulation and of the complement system. Annu Rev Biochem, 57: 321–347.
functions of the IL-10 family of cytokines in inflammation https://doi.org/10.1146/annurev.bi.57.070188.001541
and disease. Annu Rev Immunol, 29: 71–109.
26. Korytina GF, Aznabaeva YG, Akhmadishina LZ, et al.,
https://doi.org/10.1146/annurev-immunol-031210-101312
2022, The relationship between chemokine and chemokine
15. Leng RX, Pan HF, Tao JH, et al., 2011, IL-19, IL-20 and IL-24: receptor genes polymorphisms and chronic obstructive
Potential therapeutic targets for autoimmune diseases. pulmonary disease susceptibility in Tatar population from
Expert Opin Ther Targets, 15(2): 119–126. Russia: A case control study. Biochem Genet, 60(1): 54–79.
https://doi.org/10.1517 / 14728222.2011.534461 https://doi.org/10.1007/s10528-021-10087-2
16. Sun Z, Cui Y, Jin X, et al., 2014, Association between IL-4- 27. Korytina GF, Akhmadishina LZ, Aznabaeva YG, et al., 2019,
590C>T polymorphism and gastric cancer risk. Tumour Associations of the NRF2/KEAP1 pathway and antioxidant
Biol, 35(2): 1517–1521. defense gene polymorphisms with chronic obstructive
pulmonary disease. Gene, 692: 102–112.
https://doi.org/10.1007/s13277-013-1209-x
https://doi.org/10.1016/j.gene.2018.12.061
17. Mollica Poeta V, Massara M, Capucetti A, et al., 2019,
Chemokines and chemokine receptors: new targets for 28. Miller MR, Hankinson J, Brusasco V, et al.,
cancer immunotherapy. Front Immunol, 10: 379. 2005,Standardisation of spirometry. Eur Respir J, 26: 319–338.
https://doi.org/10.3389/fimmu.2019.00379 https://doi.org/10.1183 / 09031936.05.00034805
18. Brown AJ, Joseph PR, Sawant KV, et al., 2017, Chemokine CXCL7 29. Ward LD, Kellis M, 2012, HaploReg: A resource for
heterodimers: Structural insights, CXCR2 receptor function, and exploring chromatin states, conservation, and regulatory
glycosaminoglycan interactions. Int J Mol Sci, 18(4): 748. motif alterations within sets of genetically linked variants.
Nucleic Acids Res, 40: D930–D934.
https://doi.org/10.3390/ijms18040748
https://doi.org/10.1093/nar/gkr917
19. Von Hundelshausen P, Petersen F, Brandt E, 2007, Platelet-
derived chemokines in vascular biology. Thromb Haemost, 30. Purcell S, Neale B, Todd-Brown K, et al., 2007, PLINK:
97(5): 704–713. A tool set for whole-genome association and population-
based linkage analyses. Am J Hum Genet, 81(3): 559–575.
https://doi.org/10.1160/th07-01-0066
https://doi.org/10.1086 / 519795
20. Unver N, Esendagli G, Yilmaz G, et al., 2015, CXCL7-induced
macrophage infiltration in lung tumor is independent 31. Gauderman WJ, 2002, Sample size requirements for matched
of CXCR2 expression: CXCL7-induced macrophage case-control studies of gene-environment interaction. Stat
chemotaxis in LLC tumors. Cytokine, 75(2): 330–337. Med, 21(1): 35–50.
https://doi.org/10.1016/j.cyto.2015.07.018 https://doi.org/10.1002/sim.973
21. Suda T, Takahashi T, Golstein P, et al., 1993, Molecular 32. Favorov AV, Andreewski TV, Sudomoina MA, et al., 2005,
cloning and expression of the fas ligand, a novel member of A Markov chain Monte Carlo technique for identification of
the tumor necrosis factor family. Cell, 75(6): 1169–1178. combinations of allelic variants underlying complex diseases
https://doi.org/10.1016 / 0092-8674(93)90326-l in humans. Genetics, 171(4): 2113–2121.
22. Dosreis GA, Borges VM, Zin WA, 2004, The central role of https://doi.org/10.1534/genetics.105.048090
fas-ligand cell signaling in inflammatory lung diseases. J Cell 33. Benjamini Y, Hochberg Y, 1995, Controlling the false
Mol Med, 8(3): 285–293.
discovery rate: A practical and powerful approach to multiple
https://doi.org/10.1111/j.1582-4934.2004.tb00318.x testing. J R Stat Soc B (Methodological), 57: 289–300.
23. Mahmood MQ, Reid D, Ward C, et al., 2017, Transforming 34. Korytina GF, Zulkarneev SH, Aznabaeva YG, et al., 2021,
growth factor (TGF) β and SMAD signaling pathways: Contribution of IL12A, IL12B, IL13 and L12RB2 gene
1

Volume 1 Issue 1 (2022) 13 https://doi.org/10.36922/gtm.v1i1.91